Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 413 record(s)

Req # A-2020-001592

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03346550.

Organization: Health Canada

10 page(s)
April 2021

Req # A-2020-001593

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03352275.

Organization: Health Canada

8 page(s)
April 2021

Req # A-2020-001594

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03232927.

Organization: Health Canada

10 page(s)
April 2021

Req # A-2020-001603

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03331704.

Organization: Health Canada

10 page(s)
April 2021

Req # A-2020-001632

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_02581310.

Organization: Health Canada

11 page(s)
April 2021

Req # A-2020-001640

Adverse Drug Reaction (ADR) for CLOPIDOGREL BISUFATE. Report number: E2B_03194814.

Organization: Health Canada

13 page(s)
April 2021

Req # A-2020-001644

Adverse Reaction Reports (AERs) for DOCETAXEL. Report numbers: 000914051, 000914734, 000915553, 000916674, 000918041, 000918235, 000918490, 000919057, E2B_03216982, E2B_03221746, E2B_03273695.

Organization: Health Canada

85 page(s)
April 2021

Req # A-2020-001648

Adverse Reaction Reports (AERs) for FLUDARABINE PHOSPHATE. Report numbers: 916612, 916731, 000916759, 000917438, 000917442, 000917458, 000917448, 000917690, 000917819, 000918479.

Organization: Health Canada

41 page(s)
April 2021

Req # A-2020-001649

Adverse Reaction Reports (AERs) for RIFAMPICIN. Report numbers: 000914884, E2B_03183672, E2B_03183681.

Organization: Health Canada

26 page(s)
April 2021

Req # A-2020-001661

Adverse Reaction Reports (AERs) for TYLENOL. Report numbers: 000908288, 000916671, 0009917413. (ADR) for TYLENOL COMPLETE COLD, COUGH & FLU. Report number: 00090333. (ADR) for TYLENOL EXTRA STRENGTH CAPLETS. Report number: 000912956. (ADR) for TYLENOL EXTRA STRENGTH. Report number: 000915450. (ADR) for BENYLIN EXTRA STRENGTH DRY COUGH. Report number: E2B_02868658. (ADR) for RHINOCORT AQUA. Report number: E2B_02826951. (ADR) for MOTRIN. Report number: 000735297. (ADR) for CHILDREN'S MOTRIN. Report number: 000737691. (ADR) for POLYSPORIN EYE AND EAR DROPS STERILE. Report number: 000725534.

Organization: Health Canada

37 page(s)
April 2021
Date modified: